First Time Loading...

Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 125.91 USD -0.84% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. [ Read More ]

The intrinsic value of one DGX stock under the Base Case scenario is 140.36 USD. Compared to the current market price of 125.91 USD, Quest Diagnostics Inc is Undervalued by 10%.

Key Points:
DGX Intrinsic Value
Base Case
140.36 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Quest Diagnostics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling DGX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Quest Diagnostics Inc

Provide an overview of the primary business activities
of Quest Diagnostics Inc.

What unique competitive advantages
does Quest Diagnostics Inc hold over its rivals?

What risks and challenges
does Quest Diagnostics Inc face in the near future?

Has there been any significant insider trading activity
in Quest Diagnostics Inc recently?

Summarize the latest earnings call
of Quest Diagnostics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Quest Diagnostics Inc.

Provide P/S
for Quest Diagnostics Inc.

Provide P/E
for Quest Diagnostics Inc.

Provide P/OCF
for Quest Diagnostics Inc.

Provide P/FCFE
for Quest Diagnostics Inc.

Provide P/B
for Quest Diagnostics Inc.

Provide EV/S
for Quest Diagnostics Inc.

Provide EV/GP
for Quest Diagnostics Inc.

Provide EV/EBITDA
for Quest Diagnostics Inc.

Provide EV/EBIT
for Quest Diagnostics Inc.

Provide EV/OCF
for Quest Diagnostics Inc.

Provide EV/FCFF
for Quest Diagnostics Inc.

Provide EV/IC
for Quest Diagnostics Inc.

Show me price targets
for Quest Diagnostics Inc made by professional analysts.

What are the Revenue projections
for Quest Diagnostics Inc?

How accurate were the past Revenue estimates
for Quest Diagnostics Inc?

What are the Net Income projections
for Quest Diagnostics Inc?

How accurate were the past Net Income estimates
for Quest Diagnostics Inc?

What are the EPS projections
for Quest Diagnostics Inc?

How accurate were the past EPS estimates
for Quest Diagnostics Inc?

What are the EBIT projections
for Quest Diagnostics Inc?

How accurate were the past EBIT estimates
for Quest Diagnostics Inc?

Compare the revenue forecasts
for Quest Diagnostics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Quest Diagnostics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Quest Diagnostics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Quest Diagnostics Inc compared to its peers.

Compare the P/E ratios
of Quest Diagnostics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Quest Diagnostics Inc with its peers.

Analyze the financial leverage
of Quest Diagnostics Inc compared to its main competitors.

Show all profitability ratios
for Quest Diagnostics Inc.

Provide ROE
for Quest Diagnostics Inc.

Provide ROA
for Quest Diagnostics Inc.

Provide ROIC
for Quest Diagnostics Inc.

Provide ROCE
for Quest Diagnostics Inc.

Provide Gross Margin
for Quest Diagnostics Inc.

Provide Operating Margin
for Quest Diagnostics Inc.

Provide Net Margin
for Quest Diagnostics Inc.

Provide FCF Margin
for Quest Diagnostics Inc.

Show all solvency ratios
for Quest Diagnostics Inc.

Provide D/E Ratio
for Quest Diagnostics Inc.

Provide D/A Ratio
for Quest Diagnostics Inc.

Provide Interest Coverage Ratio
for Quest Diagnostics Inc.

Provide Altman Z-Score Ratio
for Quest Diagnostics Inc.

Provide Quick Ratio
for Quest Diagnostics Inc.

Provide Current Ratio
for Quest Diagnostics Inc.

Provide Cash Ratio
for Quest Diagnostics Inc.

What is the historical Revenue growth
over the last 5 years for Quest Diagnostics Inc?

What is the historical Net Income growth
over the last 5 years for Quest Diagnostics Inc?

What is the current Free Cash Flow
of Quest Diagnostics Inc?

Financials

Balance Sheet Decomposition
Quest Diagnostics Inc

Current Assets 2.4B
Cash & Short-Term Investments 686m
Receivables 1.2B
Other Current Assets 476m
Non-Current Assets 11.7B
Long-Term Investments 135m
PP&E 2.4B
Intangibles 8.9B
Other Non-Current Assets 198m
Current Liabilities 1.8B
Accounts Payable 1.4B
Accrued Liabilities 153m
Other Current Liabilities 303m
Non-Current Liabilities 5.9B
Long-Term Debt 4.4B
Other Non-Current Liabilities 1.5B
Efficiency

Earnings Waterfall
Quest Diagnostics Inc

Revenue
9.3B USD
Cost of Revenue
-6.2B USD
Gross Profit
3.1B USD
Operating Expenses
-1.8B USD
Operating Income
1.3B USD
Other Expenses
-466m USD
Net Income
850m USD

Free Cash Flow Analysis
Quest Diagnostics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

DGX Profitability Score
Profitability Due Diligence

Quest Diagnostics Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Free Cash Flow
Positive 3-Year Average ROE
Positive Gross Profit
Positive Operating Income
56/100
Profitability
Score

Quest Diagnostics Inc's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

DGX Solvency Score
Solvency Due Diligence

Quest Diagnostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
51/100
Solvency
Score

Quest Diagnostics Inc's solvency score is 51/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DGX Price Targets Summary
Quest Diagnostics Inc

Wall Street analysts forecast DGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DGX is 145.13 USD with a low forecast of 126.25 USD and a high forecast of 162.75 USD.

Lowest
Price Target
126.25 USD
0% Upside
Average
Price Target
145.13 USD
15% Upside
Highest
Price Target
162.75 USD
29% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

DGX Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

DGX Price
Quest Diagnostics Inc

1M 1M
-2%
6M 6M
+3%
1Y 1Y
-12%
3Y 3Y
0%
5Y 5Y
+60%
10Y 10Y
+155%
Annual Price Range
125.91
52w Low
120.33
52w High
146.84
Price Metrics
Average Annual Return 19.35%
Standard Deviation of Annual Returns 17.44%
Max Drawdown -37%
Shares Statistics
Market Capitalization 14B USD
Shares Outstanding 110 710 000
Percentage of Shares Shorted 2.62%

DGX Return Decomposition
Main factors of price return

What is price return decomposition?

DGX News

Other Videos

Last Important Events
Quest Diagnostics Inc

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Quest Diagnostics Inc

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Quest Diagnostics Inc Logo
Quest Diagnostics Inc

Country

United States of America

Industry

Health Care

Market Cap

14B USD

Dividend Yield

2.37%

Description

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. The company is headquartered in Secaucus, New Jersey and currently employs 40,000 full-time employees. The firm operates through DIS segment, which provides diagnostic information services to a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, accountable care organizations (ACOs) and direct contract entities (DCEs). The company is also engaged in two business operations, Diagnostic Information Services, which develops and delivers diagnostic information services that provides insights to a range of customers, and the Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company’s services primarily are provided under the Quest Diagnostics brand, but it also provides services under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne and Quanum.

Contact

NEW JERSEY
Secaucus
500 Plaza Dr
+19735202700.0
https://www.questdiagnostics.com/

IPO

1996-12-17

Employees

40 000

Officers

Chairman, CEO & President
Mr. James E. Davis
Executive VP & CFO
Mr. Sam A. Samad
Senior VP & General Counsel
Mr. Michael E. Prevoznik
Senior Vice President of Regional Businesses
Ms. Catherine T. Doherty
Senior Vice President of Diagnostic Services
Mr. Patrick T. Plewman
Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Michael J. Deppe
Show More
Senior VP and Chief Information & Digital Officer
Ms. Gabrielle Wolfson
Vice President of Investor Relations
Mr. Shawn C. Bevec
Senior VP & Chief Compliance Officer
Ms. Kristin Lee Wallace Esq.
Senior VP & Chief Communications Officer
Mr. Gary D. Samuels
Show Less

See Also

Discover More
What is the Intrinsic Value of one DGX stock?

The intrinsic value of one DGX stock under the Base Case scenario is 140.36 USD.

Is DGX stock undervalued or overvalued?

Compared to the current market price of 125.91 USD, Quest Diagnostics Inc is Undervalued by 10%.